Brookstone Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Buy
5,656
+2,157
+62% +$359K 0.01% 749
2026
Q1
$734K Buy
3,499
+988
+39% +$248K 0.01% 742
2025
Q4
$714K Buy
2,511
+100
+4% +$31.3K 0.01% 734
2025
Q3
$744K Buy
2,411
+1,583
+191% +$496K 0.01% 697
2025
Q2
$260K Buy
828
+32
+4% +$9.24K ﹤0.01% 947
2025
Q1
$209K Buy
+796
New +$215K ﹤0.01% 965

Other funds holding PODD

Brookstone Capital Management's PODD Position: Q2 2026 in Review

Brookstone Capital Management increased its Insulet (PODD) stake by 62% in Q2 2026, buying an estimated $359K and bringing the position to 5,656 shares worth $861K. The position accounts for 0.01% of the portfolio, ranked #749.

Brookstone Capital Management first reported a position in PODD in Q1 2025 and has held it in 6 quarters since. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Brookstone Capital Management held 5,656 shares of Insulet worth $861K as of Q2 2026.
  • Brookstone Capital Management bought 2,157 Insulet shares in Q2 2026, an estimated $359K.
  • Insulet made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #749 holding.
  • Brookstone Capital Management first reported a position in Insulet in Q1 2025 and has held it in 6 quarters since.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.